acyclovir suspension

Generic: acyclovir

Labeler: novadoz pharmaceuticals llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name acyclovir suspension
Generic Name acyclovir
Labeler novadoz pharmaceuticals llc
Dosage Form SUSPENSION
Routes
ORAL
Active Ingredients

acyclovir 200 mg/5mL

Manufacturer
Novadoz Pharmaceuticals LLC

Identifiers & Regulatory

Product NDC 72205-170
Product ID 72205-170_3efa1e5e-5a14-4724-a2ca-25702f10faed
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA217393
Listing Expiration 2026-12-31
Marketing Start 2023-03-09

Pharmacologic Class

Established (EPC)
herpes simplex virus nucleoside analog dna polymerase inhibitor [epc] herpes zoster virus nucleoside analog dna polymerase inhibitor [epc] herpesvirus nucleoside analog dna polymerase inhibitor [epc]
Mechanism of Action
dna polymerase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 72205170
Hyphenated Format 72205-170

Supplemental Identifiers

RxCUI
307730
UPC
0372205170728
UNII
X4HES1O11F
NUI
N0000020060 N0000180187 N0000180188 N0000175468 N0000175459

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name acyclovir suspension (source: ndc)
Generic Name acyclovir (source: ndc)
Application Number ANDA217393 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 200 mg/5mL
source: ndc
Packaging
  • 473 mL in 1 BOTTLE (72205-170-72)
source: ndc

Packages (1)

72205-170-72 473 mL in 1 BOTTLE (72205-170-72)

Ingredients (1)

acyclovir (200 mg/5mL)

Linked Drug Pages (1)

Acyclovir suspension ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "3efa1e5e-5a14-4724-a2ca-25702f10faed", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "upc": ["0372205170728"], "unii": ["X4HES1O11F"], "rxcui": ["307730"], "spl_set_id": ["3efa1e5e-5a14-4724-a2ca-25702f10faed"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["Novadoz Pharmaceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "473 mL in 1 BOTTLE (72205-170-72)", "package_ndc": "72205-170-72", "marketing_start_date": "20231023"}], "brand_name": "Acyclovir suspension", "product_id": "72205-170_3efa1e5e-5a14-4724-a2ca-25702f10faed", "dosage_form": "SUSPENSION", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "72205-170", "generic_name": "Acyclovir", "labeler_name": "Novadoz Pharmaceuticals LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acyclovir suspension", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "200 mg/5mL"}], "application_number": "ANDA217393", "marketing_category": "ANDA", "marketing_start_date": "20230309", "listing_expiration_date": "20261231"}